Pilot Study to Assess Effectiveness of Milrinone in Congenital Diaphragmatic Hernia
Anecdotal evidence suggests milrinone improves oxygenation in pulmonary hypertension associated with congenital diaphragmatic hernia.
The 6MWT is a clinically relevant and appropriate target for patients with pulmonary arterial hypertension.
Certain risk scores may not be reliable for predicting the presence of a pulmonary embolism in pregnant or postpartum women.
Several drugs may demonstrate different safety profiles and side effects that warrant a change in treatment for individuals with pulmonary hypertension.